Clarus Lifesciences III, L.P.
Clarus Ventures · adviser of record: Clarus Ventures LLC · 2014 vintage
Clarus Lifesciences III, L.P. is a 2014 venture fund managed by Clarus Ventures, with $234mm raised (Form D, amount sold). It reported $24.8mm in gross assets at year-end 2025, 0.11x its size, against a peak of $669mm in 2020.
- Latest value held
- $24.8mm year-end 2025
- Peak
- $669mm year-end 2020
- Fund size
- $234mm Form D, amount sold
- Held vs. size
- 0.11x peak 2.86x
Value held by year-end
Gross asset value reported on Form ADV at each year-end. Dashed line: fund size. Open in the Fund Tracker
| Year-end | Gross assets | ÷ size | Change |
|---|---|---|---|
| 2025 | $24.8mm | 0.11x | -43% over 2 yrs |
| 2023 | $43.3mm | 0.18x | -71% |
| 2022 | $149mm | 0.64x | -57% |
| 2021 | $343mm | 1.46x | -49% |
| 2020 | $669mm | 2.86x | +53% |
| 2019 | $436mm | 1.86x | +19% |
| 2018 | $367mm | 1.57x | -23% |
| 2017 | $479mm | 2.05x | +37% |
| 2016 | $350mm | 1.50x | -5% |
| 2015 | $368mm | 1.57x | +15% |
| 2014 | $320mm | 1.37x | – |
Other funds from Clarus Ventures
- Clarus IV-D, L.P. 2017
- Clarus Defined Exit I, L.P. 2014
- Clarus De II, L.P. 2014
- Clarus IV-A, L.P. 2011
- Clarus Lifesciences II, L.P. 2011
- Clarus Lifesciences I, L.P. 2011
About these numbers
Gross asset value is what the manager reports holding in the fund at each fiscal year-end, on SEC Form ADV, Schedule D. It includes the GP’s own commitment and is before carried interest, so it is not the LPs’ net return, and it does not show cash already distributed. A fall in value can mean distributions, markdowns or both. Fund size is the amount sold reported on Form D, which for some funds reflects only a first close. Private fund ID 805-9606722476. Data updated October 13, 2026.
Is this your fund?
Spot an error and email a correction. Facing DPI pressure? See how distribution financing works.